Sanofi (SNY) Other Accumulated Expenses (2016 - 2021)
Sanofi's Other Accumulated Expenses history spans 13 years, with the latest figure at $220.4 million for Q4 2021.
- On a quarterly basis, Other Accumulated Expenses rose 4.87% to $220.4 million in Q4 2021 year-over-year; TTM through Dec 2021 was $220.4 million, a 4.87% increase, with the full-year FY2021 number at $220.4 million, up 4.87% from a year prior.
- Other Accumulated Expenses hit $220.4 million in Q4 2021 for Sanofi, up from $210.2 million in the prior quarter.
- Over the last five years, Other Accumulated Expenses for SNY hit a ceiling of $10.8 billion in Q4 2017 and a floor of $161.3 million in Q4 2019.
- Historically, Other Accumulated Expenses has averaged $4.6 billion across 5 years, with a median of $220.4 million in 2021.
- Biggest five-year swings in Other Accumulated Expenses: surged 1984.99% in 2017 and later crashed 98.13% in 2018.
- Tracing SNY's Other Accumulated Expenses over 5 years: stood at $10.8 billion in 2017, then plummeted by 98.24% to $191.0 million in 2018, then dropped by 15.54% to $161.3 million in 2019, then soared by 30.34% to $210.2 million in 2020, then increased by 4.87% to $220.4 million in 2021.
- Business Quant data shows Other Accumulated Expenses for SNY at $220.4 million in Q4 2021, $210.2 million in Q4 2020, and $161.3 million in Q4 2019.